Third-party tested

Independent certificates of analysis are published where available.
COAs document identity and purity by HPLC. Where a certificate is published for a product, it is linked on that product page.

Research use only

Not for human or veterinary use.

Third-party tested

Independently verified for identity and purity.

Independent COAs

Available on 35+ compounds.

Order processing

Orders processed within 48 hours.

Secure ordering

Your data is always protected.

Description

GLP-1 S (5mg) / SLU-PP-332 (1mg) is an advanced oral peptide formulation designed to support metabolic regulation, weight management research, and cellular energy optimization.
GLP-1 S, a glucagon-like peptide analog, promotes satiety, regulates glucose metabolism, and supports insulin sensitivity through incretin receptor pathways.
SLU-PP-332, a selective uORF-targeting modulator, enhances mitochondrial efficiency, boosts energy expenditure, and drives fat oxidation by upregulating key metabolic processes.
Together, this dual blend provides synergistic action for research into obesity, metabolic disorders, and energy balance optimization.
Formulated for targeted metabolic and mitochondrial pathways, our GLP-1 S & SLU-PP-332 tablets offer a powerful, research-focused approach to weight regulation and cellular vitality.

Specifications

Product class Incretin analogue
Form Tablets
Quantity 5 mg per tablet
CAS 910463-68-2
Storage Store at -20C, protect from light
Restriction Research use only

Certificate of Analysis

View certificate

Our verification process

Sourced

Materials sourced from trusted global suppliers.

Batch tested

Each batch is tested for identity and purity.

Documented

COAs are published where available.

Reviewed

Results are reviewed by our testing partners.

Released

Batches are released after review.

GLP-1 S (5mg) / SLU-PP-332 (1mg) x 30 Tablets